Industry Insight

Risk Management Processes for Cell and Gene Therapies

Industry Insight: Risk Management Processes for Cell and Gene Therapies

Newly approved cell and genetic therapies are showing impressive results for patients who, otherwise, would have exhausted all treatment options. As with all product development processes, risk management is an important part of that process.

In this Industry Insight we discuss the application of Risk Management Processes to Cell & Gene Therapies.

Written by:

Ricardo Leandro

Product Manager

ValGenesis

Profile

Read Your Industry Insight